Publications

October 24, 2024

ESGCT – 2024 – Oral Presentation OR085

CD33-CLL1 Treatment System

Novel CD33/CLL-1-directed dual CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of Acute Myeloid Leukemia (AML)